Loading…

High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis

•Method developed for simultaneous assay of Amlodipine, Valsartan and Hydrochlorothiazide.•Pioglitazone used as internal standard.•Method is stability indicating as recommended by ICH.•It is validated for different validation parameters.•The present analytical method has a widespread linear concentr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2020-10, Vol.1155, p.122295-122295, Article 122295
Main Authors: Shaikh, Javed Shaikh Afzal, Raut, Santosh, Abdul, Ahad, Pathan, Mohd Arif Ali Khan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-303aa0b9715f1f2373f2ef6da275dcafe7971bbfe9dba59f7995fb54c67b4ba3
cites cdi_FETCH-LOGICAL-c365t-303aa0b9715f1f2373f2ef6da275dcafe7971bbfe9dba59f7995fb54c67b4ba3
container_end_page 122295
container_issue
container_start_page 122295
container_title Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
container_volume 1155
creator Shaikh, Javed Shaikh Afzal
Raut, Santosh
Abdul, Ahad
Pathan, Mohd Arif Ali Khan
description •Method developed for simultaneous assay of Amlodipine, Valsartan and Hydrochlorothiazide.•Pioglitazone used as internal standard.•Method is stability indicating as recommended by ICH.•It is validated for different validation parameters.•The present analytical method has a widespread linear concentration range augmenting.•The method has applicability to different strength of A.V.H. tablet formulations.•The method may also be applied for simultaneous assay of analytes in plasma and urine. A Simple, Specific, Precise, Accurate, Linear, Rugged, Robust High Performance Liquid Chromatographic method of analysis for simultaneous determination of assay of Amlodipine, Valsartan and Hydrochlorothiazide drugs in the pharmaceuticals tablet formulations using Pioglitazone as a common internal standard was developed and validated. The assay was accomplished using a mixture of acetonitrile & methanol in the volume ratio of 20:80 v/v (mobile phase B) and Ammonium acetate buffer (Mobile phase A) in gradient flow as mobile phase on an Hibar RP-18e, 250 × 4.6 mm, 5µ as chromatographic column at a flow rate of 1.300 mLmin-1, injection volume 10 µL and at a wavelength 235 nm with UV detector. Linearity of the analytical method was evaluated at a concentration range of 2.5–45.3 µg/ml for Amlodipine, 32.0–720.1 µg/ml for valsartan and 5.0–112.6 µg/ml for Hydrochlorothiazide respectively with Correlation coefficient (r) value more than 0.9997. The limit of detection (LOD) for Amlodipine, Valsartan and Hydrochlorothiazide was found to be 1.1 µg/ml, 8.0 µg/ml & 1.0 µg/ml respectively. Specificity, Method Precision, System Precision, Ruggedness, Robustness, Recovery, Stability of analytical solution, Filter paper selection study, Stress testing (Force Degradation) at various conditions were performed as per the ICH (Q2) recommendations. The chromatographic method may also be applied for simultaneous estimation of analytes in plasma and urine.
doi_str_mv 10.1016/j.jchromb.2020.122295
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2432432043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1570023220300556</els_id><sourcerecordid>2432432043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-303aa0b9715f1f2373f2ef6da275dcafe7971bbfe9dba59f7995fb54c67b4ba3</originalsourceid><addsrcrecordid>eNqFkc1q3TAQhU1oaH7aR0jRsov4RpaurXhVSmiTQqCbLLoTY_3Ec5EtR5IDzkv1Fat7fdttQaBh5ptzGE5RXFV0U9GqudltdqoPfug2jLLcY4y19UlxXt0KXnLR_HqX61rQkjLOzoqLGHeUVoIK_r4440yIqm1uz4vfD_jck8kE68MAozLE4cuMmhzEIfnnAFOPikCMsBBvCQzOa5xwNNfkFVyEkGAkMGrSLzp41TsffOoR3lAbEnGYXQaMn6NbDhimSGCaHCpI6EeSPJl6yO7KzCk3Xbwmc8j6B3pyEAfIJbglYvxQnNpMmI_H_7J4-v7t6e6hfPx5_-Pu62OpeFOnklMOQLtWVLWtLOOCW2Zso4GJWiuwRuRR11nT6g7q1oq2rW1Xb1Ujum0H_LL4vMpOwb_MJiY5YFTGufUSybZ8_-iWZ7ReURV8jMFYOQUcICyyonIfldzJY1RyH5Vco8p7n44WczcY_W_rbzYZ-LICJt_5iibIqNDkiDQGo5LUHv9j8QdVlK6G</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2432432043</pqid></control><display><type>article</type><title>High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis</title><source>Elsevier</source><creator>Shaikh, Javed Shaikh Afzal ; Raut, Santosh ; Abdul, Ahad ; Pathan, Mohd Arif Ali Khan</creator><creatorcontrib>Shaikh, Javed Shaikh Afzal ; Raut, Santosh ; Abdul, Ahad ; Pathan, Mohd Arif Ali Khan</creatorcontrib><description>•Method developed for simultaneous assay of Amlodipine, Valsartan and Hydrochlorothiazide.•Pioglitazone used as internal standard.•Method is stability indicating as recommended by ICH.•It is validated for different validation parameters.•The present analytical method has a widespread linear concentration range augmenting.•The method has applicability to different strength of A.V.H. tablet formulations.•The method may also be applied for simultaneous assay of analytes in plasma and urine. A Simple, Specific, Precise, Accurate, Linear, Rugged, Robust High Performance Liquid Chromatographic method of analysis for simultaneous determination of assay of Amlodipine, Valsartan and Hydrochlorothiazide drugs in the pharmaceuticals tablet formulations using Pioglitazone as a common internal standard was developed and validated. The assay was accomplished using a mixture of acetonitrile &amp; methanol in the volume ratio of 20:80 v/v (mobile phase B) and Ammonium acetate buffer (Mobile phase A) in gradient flow as mobile phase on an Hibar RP-18e, 250 × 4.6 mm, 5µ as chromatographic column at a flow rate of 1.300 mLmin-1, injection volume 10 µL and at a wavelength 235 nm with UV detector. Linearity of the analytical method was evaluated at a concentration range of 2.5–45.3 µg/ml for Amlodipine, 32.0–720.1 µg/ml for valsartan and 5.0–112.6 µg/ml for Hydrochlorothiazide respectively with Correlation coefficient (r) value more than 0.9997. The limit of detection (LOD) for Amlodipine, Valsartan and Hydrochlorothiazide was found to be 1.1 µg/ml, 8.0 µg/ml &amp; 1.0 µg/ml respectively. Specificity, Method Precision, System Precision, Ruggedness, Robustness, Recovery, Stability of analytical solution, Filter paper selection study, Stress testing (Force Degradation) at various conditions were performed as per the ICH (Q2) recommendations. The chromatographic method may also be applied for simultaneous estimation of analytes in plasma and urine.</description><identifier>ISSN: 1570-0232</identifier><identifier>EISSN: 1873-376X</identifier><identifier>DOI: 10.1016/j.jchromb.2020.122295</identifier><identifier>PMID: 32771968</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Amlodipine ; Amlodipine - analysis ; Assay ; Chromatography, High Pressure Liquid - methods ; Force degradation ; High performance liquid chromatographic ; Hydrochlorothiazide - analysis ; Internal standard ; Limit of Detection ; Linear Models ; Reproducibility of Results ; Tablets ; Valsartan ; Valsartan - analysis</subject><ispartof>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020-10, Vol.1155, p.122295-122295, Article 122295</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-303aa0b9715f1f2373f2ef6da275dcafe7971bbfe9dba59f7995fb54c67b4ba3</citedby><cites>FETCH-LOGICAL-c365t-303aa0b9715f1f2373f2ef6da275dcafe7971bbfe9dba59f7995fb54c67b4ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32771968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shaikh, Javed Shaikh Afzal</creatorcontrib><creatorcontrib>Raut, Santosh</creatorcontrib><creatorcontrib>Abdul, Ahad</creatorcontrib><creatorcontrib>Pathan, Mohd Arif Ali Khan</creatorcontrib><title>High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis</title><title>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</title><addtitle>J Chromatogr B Analyt Technol Biomed Life Sci</addtitle><description>•Method developed for simultaneous assay of Amlodipine, Valsartan and Hydrochlorothiazide.•Pioglitazone used as internal standard.•Method is stability indicating as recommended by ICH.•It is validated for different validation parameters.•The present analytical method has a widespread linear concentration range augmenting.•The method has applicability to different strength of A.V.H. tablet formulations.•The method may also be applied for simultaneous assay of analytes in plasma and urine. A Simple, Specific, Precise, Accurate, Linear, Rugged, Robust High Performance Liquid Chromatographic method of analysis for simultaneous determination of assay of Amlodipine, Valsartan and Hydrochlorothiazide drugs in the pharmaceuticals tablet formulations using Pioglitazone as a common internal standard was developed and validated. The assay was accomplished using a mixture of acetonitrile &amp; methanol in the volume ratio of 20:80 v/v (mobile phase B) and Ammonium acetate buffer (Mobile phase A) in gradient flow as mobile phase on an Hibar RP-18e, 250 × 4.6 mm, 5µ as chromatographic column at a flow rate of 1.300 mLmin-1, injection volume 10 µL and at a wavelength 235 nm with UV detector. Linearity of the analytical method was evaluated at a concentration range of 2.5–45.3 µg/ml for Amlodipine, 32.0–720.1 µg/ml for valsartan and 5.0–112.6 µg/ml for Hydrochlorothiazide respectively with Correlation coefficient (r) value more than 0.9997. The limit of detection (LOD) for Amlodipine, Valsartan and Hydrochlorothiazide was found to be 1.1 µg/ml, 8.0 µg/ml &amp; 1.0 µg/ml respectively. Specificity, Method Precision, System Precision, Ruggedness, Robustness, Recovery, Stability of analytical solution, Filter paper selection study, Stress testing (Force Degradation) at various conditions were performed as per the ICH (Q2) recommendations. The chromatographic method may also be applied for simultaneous estimation of analytes in plasma and urine.</description><subject>Amlodipine</subject><subject>Amlodipine - analysis</subject><subject>Assay</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Force degradation</subject><subject>High performance liquid chromatographic</subject><subject>Hydrochlorothiazide - analysis</subject><subject>Internal standard</subject><subject>Limit of Detection</subject><subject>Linear Models</subject><subject>Reproducibility of Results</subject><subject>Tablets</subject><subject>Valsartan</subject><subject>Valsartan - analysis</subject><issn>1570-0232</issn><issn>1873-376X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkc1q3TAQhU1oaH7aR0jRsov4RpaurXhVSmiTQqCbLLoTY_3Ec5EtR5IDzkv1Fat7fdttQaBh5ptzGE5RXFV0U9GqudltdqoPfug2jLLcY4y19UlxXt0KXnLR_HqX61rQkjLOzoqLGHeUVoIK_r4440yIqm1uz4vfD_jck8kE68MAozLE4cuMmhzEIfnnAFOPikCMsBBvCQzOa5xwNNfkFVyEkGAkMGrSLzp41TsffOoR3lAbEnGYXQaMn6NbDhimSGCaHCpI6EeSPJl6yO7KzCk3Xbwmc8j6B3pyEAfIJbglYvxQnNpMmI_H_7J4-v7t6e6hfPx5_-Pu62OpeFOnklMOQLtWVLWtLOOCW2Zso4GJWiuwRuRR11nT6g7q1oq2rW1Xb1Ujum0H_LL4vMpOwb_MJiY5YFTGufUSybZ8_-iWZ7ReURV8jMFYOQUcICyyonIfldzJY1RyH5Vco8p7n44WczcY_W_rbzYZ-LICJt_5iibIqNDkiDQGo5LUHv9j8QdVlK6G</recordid><startdate>20201015</startdate><enddate>20201015</enddate><creator>Shaikh, Javed Shaikh Afzal</creator><creator>Raut, Santosh</creator><creator>Abdul, Ahad</creator><creator>Pathan, Mohd Arif Ali Khan</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20201015</creationdate><title>High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis</title><author>Shaikh, Javed Shaikh Afzal ; Raut, Santosh ; Abdul, Ahad ; Pathan, Mohd Arif Ali Khan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-303aa0b9715f1f2373f2ef6da275dcafe7971bbfe9dba59f7995fb54c67b4ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amlodipine</topic><topic>Amlodipine - analysis</topic><topic>Assay</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Force degradation</topic><topic>High performance liquid chromatographic</topic><topic>Hydrochlorothiazide - analysis</topic><topic>Internal standard</topic><topic>Limit of Detection</topic><topic>Linear Models</topic><topic>Reproducibility of Results</topic><topic>Tablets</topic><topic>Valsartan</topic><topic>Valsartan - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shaikh, Javed Shaikh Afzal</creatorcontrib><creatorcontrib>Raut, Santosh</creatorcontrib><creatorcontrib>Abdul, Ahad</creatorcontrib><creatorcontrib>Pathan, Mohd Arif Ali Khan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shaikh, Javed Shaikh Afzal</au><au>Raut, Santosh</au><au>Abdul, Ahad</au><au>Pathan, Mohd Arif Ali Khan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis</atitle><jtitle>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</jtitle><addtitle>J Chromatogr B Analyt Technol Biomed Life Sci</addtitle><date>2020-10-15</date><risdate>2020</risdate><volume>1155</volume><spage>122295</spage><epage>122295</epage><pages>122295-122295</pages><artnum>122295</artnum><issn>1570-0232</issn><eissn>1873-376X</eissn><abstract>•Method developed for simultaneous assay of Amlodipine, Valsartan and Hydrochlorothiazide.•Pioglitazone used as internal standard.•Method is stability indicating as recommended by ICH.•It is validated for different validation parameters.•The present analytical method has a widespread linear concentration range augmenting.•The method has applicability to different strength of A.V.H. tablet formulations.•The method may also be applied for simultaneous assay of analytes in plasma and urine. A Simple, Specific, Precise, Accurate, Linear, Rugged, Robust High Performance Liquid Chromatographic method of analysis for simultaneous determination of assay of Amlodipine, Valsartan and Hydrochlorothiazide drugs in the pharmaceuticals tablet formulations using Pioglitazone as a common internal standard was developed and validated. The assay was accomplished using a mixture of acetonitrile &amp; methanol in the volume ratio of 20:80 v/v (mobile phase B) and Ammonium acetate buffer (Mobile phase A) in gradient flow as mobile phase on an Hibar RP-18e, 250 × 4.6 mm, 5µ as chromatographic column at a flow rate of 1.300 mLmin-1, injection volume 10 µL and at a wavelength 235 nm with UV detector. Linearity of the analytical method was evaluated at a concentration range of 2.5–45.3 µg/ml for Amlodipine, 32.0–720.1 µg/ml for valsartan and 5.0–112.6 µg/ml for Hydrochlorothiazide respectively with Correlation coefficient (r) value more than 0.9997. The limit of detection (LOD) for Amlodipine, Valsartan and Hydrochlorothiazide was found to be 1.1 µg/ml, 8.0 µg/ml &amp; 1.0 µg/ml respectively. Specificity, Method Precision, System Precision, Ruggedness, Robustness, Recovery, Stability of analytical solution, Filter paper selection study, Stress testing (Force Degradation) at various conditions were performed as per the ICH (Q2) recommendations. The chromatographic method may also be applied for simultaneous estimation of analytes in plasma and urine.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32771968</pmid><doi>10.1016/j.jchromb.2020.122295</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1570-0232
ispartof Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020-10, Vol.1155, p.122295-122295, Article 122295
issn 1570-0232
1873-376X
language eng
recordid cdi_proquest_miscellaneous_2432432043
source Elsevier
subjects Amlodipine
Amlodipine - analysis
Assay
Chromatography, High Pressure Liquid - methods
Force degradation
High performance liquid chromatographic
Hydrochlorothiazide - analysis
Internal standard
Limit of Detection
Linear Models
Reproducibility of Results
Tablets
Valsartan
Valsartan - analysis
title High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T17%3A21%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20performance%20liquid%20chromatographic%20assay%20of%20amlodipine,%20valsartan%20and%20hydrochlorothiazide%20simultaneously%20and%20its%20application%20to%20pharmaceuticals,%20urine%20and%20plasma%20analysis&rft.jtitle=Journal%20of%20chromatography.%20B,%20Analytical%20technologies%20in%20the%20biomedical%20and%20life%20sciences&rft.au=Shaikh,%20Javed%20Shaikh%20Afzal&rft.date=2020-10-15&rft.volume=1155&rft.spage=122295&rft.epage=122295&rft.pages=122295-122295&rft.artnum=122295&rft.issn=1570-0232&rft.eissn=1873-376X&rft_id=info:doi/10.1016/j.jchromb.2020.122295&rft_dat=%3Cproquest_cross%3E2432432043%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-303aa0b9715f1f2373f2ef6da275dcafe7971bbfe9dba59f7995fb54c67b4ba3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2432432043&rft_id=info:pmid/32771968&rfr_iscdi=true